J&J Settles Latest Risperdal Case Before Trial

Law360, Philadelphia (January 6, 2017, 5:23 PM EST) -- Ahead of a trial that was scheduled to get underway in Philadelphia beginning on Monday, a Johnson & Johnson unit has agreed to settle a lawsuit alleging that a New York boy grew female breasts after being treated with the antipsychotic drug Risperdal.

The settlement comes as Janssen Pharmaceuticals Inc. was gearing up to face what would have been the seventh trial over breast growth allegedly linked to the powerful antipsychotic since juries began hearing cases over the drug in earnest two years ago.

“We resolved...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.